RPS6KB1 and neuroblastoma: Western blot data (shown in Figure 5) clearly showed that all inhibitors as single agents, significantly downregulated the levels of phosphorylated p65 (NF-kB) and S6K (mTOR) molecules in all three neuroblastoma cells.